SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-045072
Filing Date
2024-05-20
Accepted
2024-05-20 13:41:12
Documents
10
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0206529-6k_akanda.htm 6-K 22238
2 FORM OF SECURITIES PURCHASE AGREEMENT ea020652901ex1-1_akanda.htm EX-1.1 195021
3 FORM OF PRE-FUNDED WARRANT ea020652901ex4-1_akanda.htm EX-4.1 83321
4 OPINION OF GOWLING WLG (CANADA) LLP ea020652901ex5-1_akanda.htm EX-5.1 35759
5 OPINION OF GOWLING WLG (CANADA) LLP ea020652901ex5-2_akanda.htm EX-5.2 35823
6 PRESS RELEASE, DATED MAY 17, 2024 ANNOUNCING CLOSING OF REGISTERED DIRECT OFFERI ea020652901ex99-1_akanda.htm EX-99.1 8214
7 PRESS RELEASE, DATED MAY 17, 2024 ANNOUNCING PRICING OF SUBSEQUENT REGISTERED DI ea020652901ex99-2_akanda.htm EX-99.2 8939
8 PRESS RELEASE, DATED MAY 20, 2024 ANNOUNCING CLOSING OF SUBSEQUENT REGISTERED DI ea020652901ex99-3_akanda.htm EX-99.3 8196
9 GRAPHIC ex5-1_001.jpg GRAPHIC 11994
10 GRAPHIC ex5-2_001.jpg GRAPHIC 11994
  Complete submission text file 0001213900-24-045072.txt   431907
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 24963607
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)